journal article·2012-08-14Open access

Extracellular Matrix Molecules Facilitating Vascular Biointegration

Steven G. Wise, Anna Waterhouse, Praveesuda Michael, Martin K.C. Ng

Abstract

All vascular implants, including stents, heart valves and graft materials exhibit suboptimal biocompatibility that significantly reduces their clinical efficacy. A range of biomolecules in the subendothelial space have been shown to play critical roles in local regulation of thrombosis, endothelial growth and smooth muscle cell proliferation, making these attractive candidates for modulation of vascular device biointegration. However, classically used biomaterial coatings, such as fibronectin and laminin, modulate only one of these components; enhancing endothelial cell attachment, but also activating platelets and triggering thrombosis. This review examines a subset of extracellular matrix molecules that have demonstrated multi-faceted vascular compatibility and accordingly are promising candidates to improve the biointegration of vascular biomaterials.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Aortic aneurysm repair treatments · Electrospun Nanofibers in Biomedical Applications · Infectious Aortic and Vascular Conditions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Heart Research Institute, Eliza Street, Newtown, NSW 2042, Australia

Wyss Institute for Biologically Inspired Engineering at Harvard, Boston, MA 02115, USA

References (100+)

Show source-provided references
1. Current status of prosthetic bypass grafts: A review10.1002/jbm.b.30247 ↗
2. Heparin-bonded dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: A multicenter trial10.1067/mva.2001.113578 ↗
3. Heparin-bonded dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial10.1016/j.jvs.2004.08.033 ↗
4. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves10.1016/j.thromres.2010.06.011 ↗
5. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials10.1161/01.CIR.103.15.1967 ↗
6. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk10.1016/j.jacc.2006.03.042 ↗
7. Stent thrombosis in 2008: Definition, predictors, prognosis and treatment10.1016/j.acvd.2008.10.006 ↗
8. Clinical end points in coronary stent trials: A case for standardized definitions10.1161/CIRCULATIONAHA.106.685313 ↗
9. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study10.1016/S0140-6736(07)60314-6 ↗
10. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (compare): A randomised trial10.1016/S0140-6736(09)62127-9 ↗
11. Passive and active polymer coatings for intracoronary stents: Novel devices to promote arterial healing10.1111/j.1540-8183.2009.00423.x ↗
12. On the mechanisms of biocompatibility10.1016/j.biomaterials.2008.04.023 ↗
13. Perfusion-decellularized matrix: Using nature’s platform to engineer a bioartificial heart10.1038/nm1684 ↗
14. Novel vascular graft grown within recipient’s own peritoneal cavity10.1161/01.RES.85.12.1173 ↗
15. Covalent immobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces10.1016/j.biomaterials.2008.11.009 ↗
16. The structure and function of platelet integrins10.1111/j.1538-7836.2009.03378.x ↗
17. Targeted delivery of thrombolytic agents: Role of integrin receptors10.1517/17425240902878002 ↗
18. Emerging roles of fibronectin in thrombosis10.1016/j.thromres.2009.12.017 ↗
19. Vitronectin is upregulated after vascular injury and vitronectin blockade prevents neointima formation10.1016/S0008-6363(01)00547-8 ↗
20. Extracellular matrix proteins are potent agonists of human smooth muscle cell migration10.1016/S0741-5214(96)70141-6 ↗
21. A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices10.1016/j.biomaterials.2009.10.051 ↗
22. Biofunctionalization of biomaterials for accelerated in situ endothelialization: A review10.1021/bm800681k ↗
23. Phosphorylcholine-based polymers and their use in the prevention of biofouling10.1016/S0927-7765(99)00152-6 ↗
24. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries10.1136/heart.83.3.338 ↗
25. Regulation of development and differentiation by the extracellular matrix10.1242/dev.117.4.1183 ↗
26. Overview of extracellular matrix
27. Signal transduction from the extracellular matrix10.1083/jcb.120.3.577 ↗
28. Cell-matrix biology in vascular tissue engineering
29. The role of endothelial cell attachment to elastic fibre molecules in the enhancement of monolayer formation and retention, and the inhibition of smooth muscle cell recruitment10.1016/j.biomaterials.2007.08.019 ↗
30. Basement membranes: Structure, assembly and role in tumour angiogenesis10.1038/nrc1094 ↗
31. Perlecan: How does one molecule do so many things?10.1007/s00018-006-6162-z ↗
32. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia10.1073/pnas.97.12.6722 ↗
33. Characterization of an in vitro model of elastic fiber assembly10.1091/mbc.10.11.3595 ↗
35. Microfibrillar elements of the dermal matrix10.1002/(SICI)1097-0029(19970815)38:4<413::AID-JEMT9>3.0.CO;2-J ↗
36. Ultrastructural properties of ciliary zonule microfibrils10.1016/S1047-8477(02)00559-2 ↗
37. Fibrillin-3 expression in human development10.1016/j.matbio.2010.10.003 ↗
38. Elastic fibres10.1242/jcs.115.14.2817 ↗
39. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids10.1111/j.1067-1927.2004.012209.x ↗
40. Molecular basis of elastic fiber formation: Critical interactions and a tropoelastin-fibrillin-1 cross-link10.1074/jbc.M400212200 ↗
41. Elastic fibres10.1242/jcs.115.14.2817 ↗
42. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene10.1038/352337a0 ↗
43. In vivo studies of mutant fibrillin-1 microfibrils10.1074/jbc.M110.130021 ↗
44. Assembly of fibrillin microfibrils governs extracellular deposition of latent tgf beta10.1242/jcs.073437 ↗
45. Molecular basis of elastic fiber formation: Critical interactions and a tropoelastin-fibrillin-1 cross-link10.1074/jbc.M400212200 ↗
46. Cell adhesion to fibrillin-1: Identification of an arg-gly-asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation10.1242/jcs.003954 ↗
47. Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins10.1074/jbc.M303159200 ↗
48. Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells
49. Fibrillins 1 and 2 perform partially overlapping functions during aortic development10.1074/jbc.M511599200 ↗
50. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of marfan syndrome10.1161/01.RES.88.1.37 ↗
51. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm10.1161/01.cir.0000087660.82721.15 ↗
52. Platelet adhesion, release and aggregation in flowing blood: Effects of surface properties and platelet function10.1055/s-0038-1647919 ↗
53. The molecular interaction between platelet and vascular wall
54. Endothelialization and patency of rgd-functionalized vascular grafts in a rabbit carotid artery model10.1016/j.biomaterials.2011.12.047 ↗
55. Surface functionalization of polyurethane for the immobilization of bioactive moieties on tissue scaffolds10.1039/b719025e ↗
56. Unraveling the mechanism of elastic fiber assembly: The roles of short fibulins10.1016/j.biocel.2010.03.009 ↗
57. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo10.1038/415168a ↗
58. Fibulin-5 binds human smooth-muscle cells through alpha5beta1 and alpha4beta1 integrins, but does not support receptor activation10.1042/BJ20070400 ↗
59. Fibulin-5 interacts with fibrillin-1 molecules and microfibrils10.1042/BJ20050368 ↗
60. Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration10.1073/pnas.0500058102 ↗
61. Fibulin-2 and fibulin-5 cooperatively function to form the internal elastic lamina and protect from vascular injury10.1161/ATVBAHA.109.196725 ↗
62. Fibulin-5, an integrin-binding matricellular protein: Its function in development and disease10.1007/s12079-009-0065-3 ↗
63. Dance, a novel secreted rgd protein expressed in developing, atherosclerotic, and balloon-injured arteries10.1074/jbc.274.32.22476 ↗
64. Effects of fibulin-5 on attachment, adhesion, and proliferation of primary human endothelial cells10.1016/j.bbrc.2006.07.156 ↗
65. Fibulin-5 is up-regulated by hypoxia in endothelial cells through a hypoxia-inducible factor-1 (hif-1alpha)-dependent mechanism10.1074/jbc.M110.162917 ↗
66. Heparan sulfate proteoglycans in healthy and diseased systems10.1002/wsbm.149 ↗
67. Colocalization in vivo and association in vitro of perlecan and elastin10.1007/s00418-011-0854-7 ↗
68. Diverse cell signaling events modulated by perlecan10.1021/bi8013938 ↗
69. Syndecans in wound healing, inflammation and vascular biology10.1016/j.biocel.2006.10.014 ↗
70. Heparan sulfate proteoglycans at a glance10.1242/jcs.03432 ↗
71. Life without perlecan has its problems10.1083/jcb.147.5.909 ↗
72. Perlecan is essential for cartilage and cephalic development10.1038/15537 ↗
73. Atherosclerosis in perlecan heterozygous mice10.1194/jlr.M400019-JLR200 ↗
74. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice10.1161/01.RES.0000026056.81424.DA ↗
75. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: An adhesion modulated by glycosaminoglycan10.1083/jcb.119.4.945 ↗
76. Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells10.1016/S0945-053X(99)00014-1 ↗
77. The role of perlecan in arterial injury and angiogenesis10.1016/j.cardiores.2004.03.028 ↗
78. Developmental regulation of perlecan gene expression in aortic smooth muscle cells10.1016/S0945-053X(96)90136-5 ↗
79. Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumor suppressor pten10.1161/01.RES.0000109791.69181.B6 ↗
80. Changes in perlecan expression during vascular injury: Role in the inhibition of smooth muscle cell proliferation in the late lesion10.1161/01.ATV.0000063109.94810.EE ↗
81. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan10.1161/01.RES.0000117772.86853.34 ↗
82. Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin10.1161/01.RES.46.5.625 ↗
83. Endothelial dysfunction, atherosclerosis and thrombosis in uremia—possibilities of intervention
84. The modulation of platelet and endothelial cell adhesion to vascular graft materials by perlecan10.1016/j.biomaterials.2009.05.063 ↗
85. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: Novel insights into the diverse biological effects of perlecan10.4244/EIJV6I1A20 ↗
86. Elastin-based materials10.1039/b919452p ↗
87. Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell10.1002/jcb.10413 ↗
88. Shape of tropoelastin, the highly extensible protein that controls human tissue elasticity10.1073/pnas.1014280108 ↗
90. Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries
91. Reduced vessel elasticity alters cardiovascular structure and function in newborn mice10.1161/CIRCRESAHA.108.192054 ↗
92. Elastin is an essential determinant of arterial morphogenesis10.1038/30522 ↗
93. Comparison of the endothelial surface and subjacent elastic lamina of anterior descending coronary arteries at the location of atheromatous lesions with internal thoracic arteries of the same subjects: A scanning electron microscopic study10.1080/0031302021000009351 ↗
94. Effect of coacervated alpha-elastin on proliferation of vascular smooth muscle and endothelial cells10.1177/000331979804900407 ↗
95. Elastin repeat peptides as chemoattractants for bovine aortic endothelial cells10.1002/jcp.1041400316 ↗
96. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of mt1-mmp10.1242/jcs.01613 ↗
97. In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application10.1002/jbm.a.31287 ↗
98. A multilayered synthetic human elastin/polycaprolactone hybrid vascular graft with tailored mechanical properties10.1016/j.actbio.2010.07.022 ↗
99. Novel approach for endothelializing vascular devices: Understanding and exploiting elastin-endothelial interactions10.1007/s10439-010-0142-z ↗
100. Elastin induces myofibrillogenesis via a specific domain, vgvapg10.1016/S0945-053X(03)00076-3 ↗